Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
Piper Sandler analyst Edward A. Tenthoff previews year-end for Biotechnology.The analyst commented: "Look for Biotech to Outperform through YE:26 with ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)